XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Cash Flows (Unaudited)
 9 Months Ended
Sep. 30, 2025
USD ($)
Cash Flows from Operating Activities:  
Net income $ 4,986,136
Adjustments to reconcile net income to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (5,383,501)
Changes in operating assets and liabilities:  
Prepaid expenses (31,957)
Prepaid insurance (91,779)
Accrued expenses 931
Due to related party (3,002)
Net cash used in operating activities (523,172)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (301,650,750)
Net cash used in investing activities (301,650,750)
Cash Flows from Financing Activities:  
Proceeds from sale of Public Units, net of underwriting discounts paid 294,930,000
Proceeds from sale of Private Placement Units 8,720,750
Due from Sponsor (366,125)
Repayment of due from Sponsor 366,125
Proceeds from IPO Promissory Note - related party 217,025
Repayment of IPO Promissory Note - related party (285,045)
Payment of offering costs (490,772)
Net cash provided by financing activities 303,091,958
Net Change in Cash 918,036
Cash – Beginning of period
Cash – End of period 918,036
Non-Cash investing and financing activities:  
Offering costs included in accrued offering costs 75,000
Accretion of Class A Ordinary Shares to redemption value 26,802,736
Deferred underwriting fee payable $ 12,789,000